Driving Longevity and Treating Diseases of Aging Using Cellular Rejuvenation with Boris Reznik Immorta Bio TRANSCRIPT
Download PDFOct 2, 2024
Dr. Boris Reznik, Chairman and CEO of Immorta Bio, was founded to explore longevity and life extension technologies inspired by the discovery that aged cells can be reprogrammed to become younger ones. The company has a cellular rejuvenation platform that uses the patient's cells and senolytic immunotherapy to help the immune system target and remove senescent cells. These approaches aim to leverage the body's natural mechanism for maintaining health and extending the healthspan, not just lifespan.
Boris explains, "First of all, let me just touch upon aging because aging perpetually happens on a cellular level from an early age because trillions of mutations occur in our cells every single day. But the young body’s defense mechanism, such as the immune system and stem cells, effectively addresses those issues and keeps young people healthy. So everything we do is associated with the approach where we try to use young bodies’ mechanisms in dealing with all diseases and all issues associated with aging."
"As I said, young bodies have mechanisms, but all mechanisms which body uses, they have a tendency to deteriorate with age, and it starts all on cellular level. They progress from cells to tissues, from tissues to organs, from organs to systems, and, eventually, all of that results in a disease. And those diseases are what we call diseases of aging. So, actually, the disease of aging is just a specific stage of aging. So, what we created and what we focus on are the two fundamental areas of longevity technologies."
#ImmortaBio #Longevity #StemCells #Cancer #Aging #Rejuvenation
